OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Optimizing these processes involves adjusting various factors, including cell line development, media formulation, and bioreactor conditions. A key goal is to amplify antibody yield while reducing production expenses